Benitec Biopharma Inc. Ratios

Ratios Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Profitability
Gross Margin 96.43%-81.37%-108.47%87.67%
EBT Margin 22.17%-8,057.84%-23,054.24%-24,501.37%-25,485.33%
EBIT Margin 21.17%-8,118.63%-23,044.07%-24,457.53%-25,441.33%
EBITDA Margin 17.03%-8,199.02%-22,684.75%-24,654.79%-25,529.33%
Operating Margin 21.17%-8,118.63%-23,044.07%-24,457.53%-25,441.33%
Net Margin 22.17%-8,057.84%-23,054.24%-24,501.37%-26,082.67%
FCF Margin 35.95%-7,480.39%-22,123.73%-21,798.63%-24,017.33%
Efficiency
Assets Average 15.41M16.48M13.68M5.22M28.34M
Equity Average 13.42M15.12M11.45M1.54M23.73M
Invested Capital 16.59M10.24M20.01M2.88M0.20M47.25M
Asset Utilization Ratio 0.010.000.010.01
Leverage & Solvency
Equity Ratio 0.860.880.940.480.050.90
Valuation
Enterprise Value -6.09M0.36M13.60M5.40M4.18M14.55M299.52M
Market Capitalization 9.62M10.17M33.38M9.48M6.67M65.48M299.52M
Return Ratios
Return on Sales 0.22%-80.58%-230.54%-245.01%-254.85%
Return on Capital Employed -0.58%-0.90%-1.60%-15.38%-0.96%
Return on Assets -0.53%-0.83%-1.31%-3.66%-0.76%
Return on Equity -0.61%-0.90%-1.56%-12.40%-0.91%